Zinc Oxide 100% exempt from Pharmaceutical Tariifs
| Stock | Advance Zinctek Ltd (ANO.ASX) |
|---|---|
| Release Time | 8 Apr 2026, 2:10 p.m. |
| Price Sensitive | Yes |
Zinc Oxide Exempt from Pharmaceutical Tariffs
- Zinc oxide classified as a critical mineral, exempt from 100% tariffs on pharmaceuticals
- BASF raises prices of UV chemical filter ingredients by 30%
- Increase in debtor insurance claims of 158% in February
Advance ZincTek Ltd has announced that zinc oxide, a key ingredient used in its products, is currently classified as a critical mineral by the US Geological Survey and Department of the Interior since 2022. This means that zinc oxide is exempt from the current proposed 100% tariffs on pharmaceuticals. The company also noted that on April 1, 2026, the UV chemical giant BASF has raised prices of ingredients used in their UV chemical filters by 30%. Additionally, a recent report from the credit insurer NCI has highlighted an increase in debtor insurance claims of 158% for the month of February. Despite these industry trends, Advance ZincTek Ltd remains debt-free with no debtors outside their trading terms. The company's sales for the period ending 31 March 2026 were $9.589 million, up 11.28% compared to the prior corresponding period of $8.617 million, based on unaudited management accounts.
Sales to 31 March 2026 were $9.589 million, up 11.28% compared to the prior corresponding period.